stockrowHenry Schein, Inc.
HSIC Healthcare Medical Distribution
Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024.
- Revenue
- +3.95%
- EPS
- +34.8%
- Free cash flow
- −7.09%
- Total debt
- +15.6%
Quarter to September 2026, against a year earlier
Follow HSIC
Alert me
Henry Schein, Inc. (HSIC) Return on equity
Henry Schein, Inc.'s return on equity over the twelve months to 30 September 2026 was 10.7%, up 0.7 percentage points from fiscal 2025 (10.0%). Over the past ten years it has ranged from 9.38% (fiscal 2024) to 19.4% (fiscal 2019); the current reading is higher than 27% of that period. That is above the Medical Distribution industry median of 0.00% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 10.0% | 0.66 |
| FY2024 | 9.38% | (0.54) |
| FY2023 | 9.92% | (3.27) |
| FY2022 | 13.2% | (2.49) |
| FY2021 | 15.7% | 5.07 |
| FY2020 | 10.6% | (8.76) |
| FY2019 | 19.4% | 2.53 |
| FY2018 | 16.8% | 2.39 |
| FY2017 | 14.5% | (3.37) |
| FY2016 | 17.8% | 1.02 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| ACH Accendra Health, Inc. compare | 72.6% |
| YI 111, Inc. Sponsored ADR compare | 12.3% |
| HSIC Henry Schein, Inc. | 10.7% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| COR Cencora, Inc. compare | 0.00% |
| CAH Cardinal Health, Inc. compare | −65.0% |
| COSM Cosmos Health Inc. compare | −104.0% |
| FOCL FocalTherics compare | −133.5% |
| MCK McKesson Corporation compare | −190.5% |
| Medical Distribution industry median | 0.00% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on HSIC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement